The GLP-1 paradox: too expensive to cover, too effective to cut A founder and a former HHS CTO agree: GLPs are breaking the healthcare system. We need to move away from drug-first or diet-first obesity care. Fortune · Jul 23
Gold card health scheme to cover obesity surgery The National Health Security Office (NHSO) has expanded benefits under the Universal Coverage Scheme, commonly known as the 30-baht gold card scheme, to include surgery for patients with severe obesity who meet strict medical criteria. Bangkok Post · Jul 22
Type 2 Diabetes Jumped 69% in Young Women, Nearly 60% Higher Than in Men, as Obesity Starts Earlier A study reveals a 69% rise in type 2 diabetes among young women in England since 2011, highlighting early obesity as a key factor. The NHS is responding with targeted initiatives. International Business Times UK · Jul 22
Target ultra-processed food to reduce obesity in Britain Letter: James Capon responds to an editorial on the health select committee’s call for radical action to regulate food markets The Guardian - UK · Jul 22
GLP-1 Drugs Like Ozempic Carry Elevated Risks of Muscle Loss and Malnutrition in Adults Over 65 GLP-1 drugs carry higher muscle loss, malnutrition, and bone density risks in adults over 65 that younger users don't face. Here's what older patients and prescribers need to know. Medical Daily · Jul 21
Loneliness Is a Bigger Health Risk Than Obesity, Here Is What the Research Shows on Social Isolation The study that changed how doctors think about lonelinessIn 2015, psychologist Julianne Holt-Lunstad at Brigham Young University published a meta-analysis in Perspectives on Psychological Science covering 148 studies and roughly 308,000 participants. The finding: people with strong social connections had a 50% greater likelihood of survival over a given period… Times Life · Jul 21
A tax on sugary drinks in Egypt could reduce disease and save US$1.8 billion in healthcare costs: modelling study Non-communicable diseases – heart disease, stroke, diabetes, cancer – are no longer just a rich-country problem. Across Africa, they are becoming the leading cause of death, driven in part by a simple and overlooked culprit: what people drink. The Conversation · Jul 20
Why the same foods you eat during the day can lead to belly fat, higher blood sugar & poorer cholesterol levels at night; study has the answer Night owls consuming high-energy foods late at night show greater body fat. Evening-types eat less in the morning and more after 8 pm. This eating pattern is associated with higher body fat percentage and obesity risk. Women preferring later bedtimes had poorer lipid profiles and glucose regulation. Meal timing, especially… The Economic Times · Jul 20
US obesity crisis: Not losing weight despite exercising? American Heart Association study reveals the surprising truth about your health beyond the scale, blood pressure and cholesterol Weight loss tips: Regular exercise offers significant health benefits, even without substantial weight loss. Increasing physical activity alone may not lead to major weight reduction. Strength training is crucial for preserving muscle mass during weight loss efforts. Maintaining weight loss often requires more extensive physical activity weekly. Successful weight management… The Economic Times · Jul 19
Stopping Ozempic or Wegovy Leads to Nearly 2 Pounds of Weight Regain Per Month, Largest Review Finds Oxford study of 9,341 adults finds stopping Ozempic or Wegovy causes ~1.8 lbs of weight regain per month. What patients need to know about GLP-1 discontinuation. Medical Daily · Jul 17
Novo Nordisk's obesity drug Wegovy wins India approval to fight silent fatty liver killer India's drug regulator approved Novo Nordisk's Wegovy for MASH treatment. This drug targets a serious progressive form of fatty liver disease. The approval follows a committee recommendation for adults with moderate to advanced liver fibrosis. Wegovy, containing semaglutide, was previously approved for chronic weight management. This marks a significant expansion… The Economic Times · Jul 17
How can we better support families to make healthier food choices? The food industry, government and wider society can build a healthier future for children and their families – but the issues are complex, as a recent panel of experts found The Guardian - UK · Jul 17
Fatty Liver? These 3 Science-Backed Drinks May Help Fatty liver disease often develops silently, showing few or no symptoms until the condition becomes more serious. Modern lifestyles, processed foods, lack of exercise, and excess alcohol have made it increasingly common worldwide. While there is no magic drink that can cure fatty liver, experts say that combining a healthy… MyLifeXP · Jul 17
Energy Drinks Ban Sees England Block High-Caffeine Drinks for Under-16s From 2027 From April 2027, England will ban sales of high-caffeine energy drinks to under-16s, aiming to protect children's health amid concerns over caffeine's impact on sleep, concentration, and obesity. International Business Times UK · Jul 17
Medical Daily · Jul 15 A Record 40 Million Americans Are Now Taking GLP-1 Weight-Loss Drugs as Medicare Coverage Begins A Gallup survey shows 11% of Americans now take GLP-1 drugs for weight loss as Medicare begins covering them for $50 monthly. Here's what it means for you.
MyLifeXP · Jul 15 The Health Tests You Should Get In Your 20s Even If You Feel Perfectly Healthy Feeling healthy does not always mean everything is perfect inside your body. High cholesterol, vitamin deficiencies, diabetes, high blood pressure, and even certain infections can go unnoticed for years without causing obvious symptoms. Your 20s are the ideal time to create a baseline for your health. Regular screenings are not…
The Guardian - UK · Jul 15 The Guardian view on obesity: put public health before food industry pressure Editorial: Obesity reflects prices, advertising and access, not simply weak willpower. Ministers must now act
MyLifeXP · Jul 15 The Most Misunderstood Indian Foods And The Myths Around Them Indian cuisine is one of the world's most diverse and nutritious food traditions. Built around grains, pulses, spices, dairy, and seasonal vegetables, it has evolved over centuries through local wisdom and regional practices. Yet many traditional foods have become victims of misinformation. Social media trends, fad diets, and half understood…
Medical Daily · Jul 15 Ozempic's Active Ingredient May Slow Biological Aging, First Human Clinical Trial Finds A clinical trial published in Nature Communications found semaglutide slowed biological aging markers in adults with HIV. Here's what the research actually shows.
The Guardian - UK · Jul 14 MPs call for ban on fast food outlets opening near schools to tackle obesity Commons health committee also recommends end to junk food advertising on billboards and public transport
The Independent UK · Jul 14 Supermarkets could be hit with penalties over junk food sales under new proposals to tackle obesity The Health and Social Care Committee has also called for all outdoor advertising of junk food to be banned
Evening Standard · Jul 14 Government must ‘stand up to the food industry’ to tackle obesity epidemic – MPs All outdoor advertising of junk food should be banned and front-of-pack labelling should be mandatory, the Health and Social Care Committee said.
The Independent UK · Jul 14 Being out-of-shape raises risk of type 2 diabetes by more than 3 times, researchers warn 15 percent of people with both excess body fat and poor muscle health developed type 2 diabetes within a decade, study finds
International Business Times UK · Jul 14 Trump Weight Gain: Doctor Reveals Body Mass Index Is on the Verge of Obesity US President Donald Trump's recent medical exam shows a BMI of 29.7, sparking debate over his health and transparency. Concerns include weight gain, cognitive assessments, and public disclosure practices.
Medical Daily · Jul 14 GLP-1 Drugs Like Ozempic and Wegovy May Be Improving a Painful Skin Disease, Dermatologists Say New evidence links GLP-1 drugs like Ozempic and Wegovy to significant improvements in psoriasis and hidradenitis suppurativa. Dermatologists explain what the data show and who may benefit.